Recent News:
2022
2020
New progress in the development of treatments for patients diagnosed with triple negative breast cancer
- • Alternatives for triple negative breast cancer
- • Nature Communications - GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Lab Affiliations:
Princess Margaret Cancer Centre
|
Structural Genomics Consortium | University of Toronto |
Funding:
Terry Fox Foundation | Huntington Society Canada |
Lymphoma Leukemia Society
|
Canada Institutes of Health Research
|
NSERC |
SU2C
|
Lab Members Online:
Rachel Harding | Open Lab Notebooks |
Collaborators:
Penn Lab | Raught Lab | Lupien Lab |